Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Biol Pharm Bull ; 33(4): 707-9, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20410610

RESUMEN

CCl(4) (0.5 ml/kg as CCl(4)) was orally administered to rats. Twelve hours after administration of CCl(4), plasma alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels, indicators of liver necrosis, were significantly higher than those in the control group showing that active liver necrosis took place. At the same time the level of liver vitamin C was decreased significantly compared to that in the control group. Oral administration of 100 mg/kg each of celecoxib 3 and 8 h after CCl(4) treatment did not change plasma ALT and AST and liver vitamin C levels 12 h after CCl(4) treatment, but 24 h after CCl(4) treatment, significantly decreased plasma ALT and AST levels and elevated liver vitamin C level. These finding suggested that celecoxib effectively ameliorated the necrotic action and the oxidative stress induced by CCl(4) in the second phase. Although the plasma levels of all ceramide species were significantly increased 24 h after CCl(4) intoxication, treatment with celecoxib significantly reduced the total ceramide concentration in plasma. These results indicated that celecoxib significantly ameliorated the toxicity of CCl(4) in the second phase.


Asunto(s)
Antioxidantes/farmacología , Intoxicación por Tetracloruro de Carbono/tratamiento farmacológico , Enfermedad Hepática Inducida por Sustancias y Drogas/prevención & control , Inhibidores de la Ciclooxigenasa 2/farmacología , Hígado/efectos de los fármacos , Pirazoles/farmacología , Sulfonamidas/farmacología , Alanina Transaminasa/sangre , Animales , Antioxidantes/uso terapéutico , Ácido Ascórbico/metabolismo , Aspartato Aminotransferasas/sangre , Intoxicación por Tetracloruro de Carbono/metabolismo , Celecoxib , Ceramidas/sangre , Enfermedad Hepática Inducida por Sustancias y Drogas/complicaciones , Enfermedad Hepática Inducida por Sustancias y Drogas/metabolismo , Inhibidores de la Ciclooxigenasa 2/uso terapéutico , Hígado/metabolismo , Masculino , Necrosis/etiología , Necrosis/prevención & control , Estrés Oxidativo/efectos de los fármacos , Pirazoles/uso terapéutico , Ratas , Ratas Wistar , Sulfonamidas/uso terapéutico
2.
Biosci Biotechnol Biochem ; 74(5): 979-83, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20460729

RESUMEN

Rat liver was subjected to two-thirds warm ischemia for 45 min and reperfusion (I/R) to evaluate the resulting oxidative stress. The plasma alanine aminotransferase and aspartate aminotransferase activities were significantly higher than those in the sham group 1.5-24 h after I/R, showing extensive liver cell death. The level of oxidative stress was compared between the ischemic and non-ischemic regions based on the change in antioxidative vitamins C and E. The vitamin C level was significantly decreased during I/R in both the ischemic and non-ischemic regions 0, 1.5, 3, 6, 12, and 24 h after the start of reperfusion, showing enhanced oxidative stress even in the non-ischemic lobules. This decrease of vitamin C in the ischemic region was significantly higher than that in the non-ischemic lobules, while the vitamin E content was decreased only in the ischemic lobes, demonstrating higher oxidative stress in the ischemic region than that in the non-ischemic region. Early transient activation of cytoprotective extracellular signal-related kinase (ERK) was apparent in both the ischemic and non-ischemic lobules, reflecting oxidative stress in both regions. Early transient activation of c-Jun NH(2)-terminal kinase (JNK) was only apparent in the ischemic region, corresponding to extensive oxidative stress and liver cell death. These results demonstrate that significant oxidative stress was induced, but that JNK leading to cell death was not activated in the non-ischemic part of the liver.


Asunto(s)
Isquemia/metabolismo , Hígado/irrigación sanguínea , Hígado/metabolismo , Estrés Oxidativo , Daño por Reperfusión/metabolismo , Daño por Reperfusión/fisiopatología , Alanina Transaminasa/sangre , Animales , Ácido Ascórbico/sangre , Ácido Ascórbico/metabolismo , Aspartato Aminotransferasas/sangre , Hígado/enzimología , Masculino , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Ratas , Ratas Wistar , Daño por Reperfusión/sangre , Daño por Reperfusión/enzimología , Vitamina E/sangre , Vitamina E/metabolismo
3.
Arch Toxicol ; 83(5): 477-83, 2009 May.
Artículo en Inglés | MEDLINE | ID: mdl-19066852

RESUMEN

Carbon tetrachloride (1 ml/kg body weight as a 1:1 mixture of CCl(4) and mineral oil) was orally administered to rats. After 12 h, the activity of plasma ALT (alanine aminotransferase) was significantly higher than that of the control group, and plasma ALT and AST (aspartate aminotransferase) activities significantly increased 24 h after CCl(4) administration. These results indicated that the necrotic process had initiated at about 12 h and developed thereafter. After 6-24 h of CCl(4) administration, the hepatic level of vitamin C, the most sensitive indicator of oxidative stress, decreased significantly, indicating that oxidative stress was significantly enhanced 6 h after CCl(4) intoxication and thereafter. Oral administration of vitamin E (1 ml/kg body weight as a 1:1 mixture of alpha-tocopherol and mineral oil) 12 h before CCl(4) administration caused a significant elevation of liver vitamin E level and ameliorated liver necrosis 24 h after CCl(4) intoxication based on plasma AST and ALT. Vitamin E also significantly restored the hepatic vitamin C concentration 12 and 24 h after CCl(4) intoxication, demonstrating that vitamin E functioned as an antioxidant. The liver vitamin E concentration was not changed by vitamin E supplementation to rats that did not receive CCl(4). This result indicated that vitamin E accumulated in the damaged liver. The activation of JNK, ERK1/2 and p38 MAPK took place 1.5 h after CCl(4) administration. Co-administration of alpha-tocopherol with CCl(4) did not affect these early changes in MAPKs.


Asunto(s)
Intoxicación por Tetracloruro de Carbono/metabolismo , Hígado/metabolismo , alfa-Tocoferol/metabolismo , Alanina Transaminasa/sangre , Animales , Ácido Ascórbico/análisis , Ácido Ascórbico/metabolismo , Aspartato Aminotransferasas/sangre , Intoxicación por Tetracloruro de Carbono/patología , Hígado/patología , Masculino , Necrosis/inducido químicamente , Necrosis/metabolismo , Ratas , Ratas Wistar , Factores de Tiempo , Vitamina E/metabolismo
4.
J Nutr Sci Vitaminol (Tokyo) ; 53(2): 160-5, 2007 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-17616004

RESUMEN

D-Galactosamine (D-Galn: 300 mg/kg) was intraperitoneally administered to rats. After 6 h the activity of plasma GOT and GPT was significantly higher than that of the control group and plasma GOT and GPT activities increased thereafter. These results indicated that the necrotic process was initiated at about 6 h and developed thereafter. With coadministration of DMSO (1 h before administration of D-Galn: 2.5 mL/kg, oral), plasma GOT and GPT were significantly lower, showing that DMSO inhibited the necrotic action of D-Galn. After 6-24 h of D-Galn administration, the hepatic level of vitamin C, the most sensitive indicator of oxidative stress, decreased significantly, indicating that oxidative stress was significantly enhanced 6 h after D-Galn intoxication and thereafter. DMSO significantly restored the liver vitamin C level 24 h after D-Galn injection, demonstrating that DMSO effectively ameliorated the oxidative stress caused by D-Galn, resulting in the prevention of necrosis of the liver. Phosphorylated JNK and phospho-ERK were significantly increased transiently 6-12 h after treatment with D-Galn. These results indicated that oxidative stress and the activation of JNK took place almost simultaneously. Phosphorylated p38 MAPK was not changed and DMSO treatment did not affect the change of these MAPKs by D-Galn.


Asunto(s)
Dimetilsulfóxido/farmacología , Depuradores de Radicales Libres/farmacología , Galactosamina/toxicidad , Hígado/patología , Estrés Oxidativo/efectos de los fármacos , Alanina Transaminasa/sangre , Alanina Transaminasa/efectos de los fármacos , Análisis de Varianza , Animales , Ácido Ascórbico/sangre , Ácido Ascórbico/metabolismo , Aspartato Aminotransferasas/sangre , Aspartato Aminotransferasas/efectos de los fármacos , Western Blotting/métodos , Modelos Animales de Enfermedad , Hígado/efectos de los fármacos , Masculino , Proteínas Quinasas Activadas por Mitógenos/efectos de los fármacos , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Necrosis/inducido químicamente , Necrosis/prevención & control , Ratas , Ratas Wistar , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA